Chloroquinoxaline Sulfonamide in Treating Patients With Small Cell Lung Cancer
Status:
Completed
Trial end date:
2002-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of chloroquinoxaline sulfonamide in
treating patients who have small cell lung cancer that has not responded to platinum-based
chemotherapy.